By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian fluorescence and protein detection technologies firm Fluorotechnics, which is undergoing a restructuring, reported that revenues for the second half of 2010 fell 32 percent year over year to A$1.3 million ($1.3 million) from A$1.8 million.

For the six months ended Dec. 31, 2010, sales to external customers shrank to A$1.2 million, a 33 percent drop-off from $1.8 million a year ago, while other revenues nearly doubled to A$144,341 from A$73,040.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.